» Articles » PMID: 36977140

Barriers and Facilitators to HIV Treatment Adherence in Indonesia: Perspectives of People Living with HIV and HIV Service Providers

Overview
Date 2023 Mar 28
PMID 36977140
Authors
Affiliations
Soon will be listed here.
Abstract

HIV treatment adherence in Indonesia is a major challenge. Although previous studies have demonstrated several barriers and facilitators to adherence, studies providing a comprehensive analysis from both PLHIV and HIV service providers' perspectives are limited, especially in Indonesia. In this qualitative study with 30 people living with HIV on treatment (PLHIV-OT) and 20 HIV service providers (HSPs), we explored, via online interviews, the barriers and facilitators to antiretroviral therapy (ART) adherence using a socioecological approach. Both PLHIV-OT and HSPs reported stigma as a major barrier at each socioecological level, including public stigma at the societal level, stigma in healthcare settings, and self-stigma at the intrapersonal level. Stigma reduction must therefore be prioritized. PLHIV-OT and HSPs also reported support from significant others and HSPs as the foremost facilitators to ART adherence. The enablement of support networks is thus an important key to improved ART adherence. Overall, the societal level and health system barriers to ART adherence should be addressed in order to remove barriers and enhance the facilitators at the subordinate socioecological levels.

Citing Articles

HIV/AIDS in Indonesia: current treatment landscape, future therapeutic horizons, and herbal approaches.

Jocelyn , Nasution F, Nasution N, Asshiddiqi M, Kimura N, Siburian M Front Public Health. 2024; 12:1298297.

PMID: 38420030 PMC: 10899510. DOI: 10.3389/fpubh.2024.1298297.


Wakakosha "You are Worth it": reported impact of a community-based, peer-led HIV self-stigma intervention to improve self-worth and wellbeing among young people living with HIV in Zimbabwe.

France N, Byrne E, Nyamwanza O, Munatsi V, Willis N, Conroy R Front Public Health. 2023; 11:1235150.

PMID: 37575105 PMC: 10422020. DOI: 10.3389/fpubh.2023.1235150.


Does adherence to antiretroviral therapy differ by place of residence in Nigeria? A systematic review and meta-analysis protocol.

Badru O, Bain L, Adeagbo O BMJ Open. 2023; 13(7):e070024.

PMID: 37491090 PMC: 10373693. DOI: 10.1136/bmjopen-2022-070024.


Emerging Diseases/Viruses Prevention, Control, Surveillance, and One Health.

Simonin Y Trop Med Infect Dis. 2023; 8(5).

PMID: 37235305 PMC: 10221003. DOI: 10.3390/tropicalmed8050257.

References
1.
Bor J, Fischer C, Modi M, Richman B, Kinker C, King R . Changing Knowledge and Attitudes Towards HIV Treatment-as-Prevention and "Undetectable = Untransmittable": A Systematic Review. AIDS Behav. 2021; 25(12):4209-4224. PMC: 8147591. DOI: 10.1007/s10461-021-03296-8. View

2.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

3.
Ameli V, Taj L, Barlow J, Sabin L, Meinck F, Haberer J . 'You just prefer to die early!': how socioecological context impedes treatment for people living with HIV in Iran. BMJ Glob Health. 2021; 6(11). PMC: 8603297. DOI: 10.1136/bmjgh-2021-006088. View

4.
Sianturi E, Latifah E, Gunawan E, Sihombing R, Parut A, Perwitasari D . Adaptive Stigma Coping Among Papuans Living with HIV: a Qualitative Study in One of the Indigenous People, Indonesia. J Racial Ethn Health Disparities. 2022; 10(5):2244-2251. DOI: 10.1007/s40615-022-01403-6. View

5.
Utami S, Sawitri A, Wulandari L, Putra I, Astuti P, Wirawan D . Mortality among people living with HIV on antiretroviral treatment in Bali, Indonesia: incidence and predictors. Int J STD AIDS. 2017; 28(12):1199-1207. DOI: 10.1177/0956462417692942. View